Joel Shyam Klinton
Biographic Data
| ID | 6170419 |
|---|---|
| NAME | Joel Shyam Klinton |
| GIVEN NAMES | Joel Shyam |
| FAMILY NAME | Klinton |
| SIGNATURE | KLINTON J S |
| AFFILIATIONS | McGill University Health Centre |
| ORCID | 0000-0003-4850-3961 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Barriers and facilitators to antibiotic stewardship in Nigeria’s private healthcare sector: A qualitative interview study with national health and regulatory interest holders
Antimicrobial resistance (AMR) poses a growing global health concern, particularly in low- and middle-income countries (LMICs) such as Nigeria, where stewardship efforts have largely overlooked the private healthcare sector. Given that most Nigerians seek care from private providers, understanding the barriers and opportunities for implementing antibiotic stewardship programs in this setting is critical. We conducted a qualitative study consistin…
Health and tuberculosis systems resilience, the role of the private sector and pandemic preparedness: Insights from a cross-country qualitative study with policy-makers in India, Indonesia and Nigeria
Introduction The COVID-19 pandemic was an unprecedented challenge to health systems worldwide and had a severe impact on tuberculosis (TB) case notifications and service delivery. India, Indonesia and Nigeria are high TB-burden countries where the majority of initial care-seeking happens in the private health sector. The objectives of this study were to (1) explore policy-makers’ perspectives on the impact of the COVID-19 pandemic on private sect…
Unlocking the potential of informal healthcare providers in tuberculosis care: Insights from India
In 2022, tuberculosis (TB) remained a major global health concern, second only to COVID-19 in mortality from a single infectious agent
Pharmacy engagement in TB prevention and care: Not if, but how
Tuberculosis in times of Covid-19
The COVID-19 pandemic has caused widespread disruptions to tuberculosis (TB) care and service delivery in 2020, setting back progress in the fight against TB by several years. As newer COVID-19 variants continue to devastate many low and middle-income countries in 2021, the extent of this setback is likely to increase. Despite these challenges, the TB community can draw on the comprehensive approaches used to manage COVID-19 to help restore progr…
Tuberculosis in times of Covid-19
The COVID-19 pandemic has caused widespread disruptions to tuberculosis (TB) care and service delivery in 2020, setting back progress in the fight against TB by several years. As newer COVID-19 variants continue to devastate many low and middle-income countries in 2021, the extent of this setback is likely to increase. Despite these challenges, the TB community can draw on the comprehensive approaches used to manage COVID-19 to help restore progr…
Tuberculosis in times of Covid-19
The COVID-19 pandemic has caused widespread disruptions to tuberculosis (TB) care and service delivery in 2020, setting back progress in the fight against TB by several years. As newer COVID-19 variants continue to devastate many low and middle-income countries in 2021, the extent of this setback is likely to increase. Despite these challenges, the TB community can draw on the comprehensive approaches used to manage COVID-19 to help restore progr…
Pharmacy engagement in TB prevention and care: Not if, but how
Unlocking the potential of informal healthcare providers in tuberculosis care: Insights from India
In 2022, tuberculosis (TB) remained a major global health concern, second only to COVID-19 in mortality from a single infectious agent
Health and tuberculosis systems resilience, the role of the private sector and pandemic preparedness: Insights from a cross-country qualitative study with policy-makers in India, Indonesia and Nigeria
Introduction The COVID-19 pandemic was an unprecedented challenge to health systems worldwide and had a severe impact on tuberculosis (TB) case notifications and service delivery. India, Indonesia and Nigeria are high TB-burden countries where the majority of initial care-seeking happens in the private health sector. The objectives of this study were to (1) explore policy-makers’ perspectives on the impact of the COVID-19 pandemic on private sect…
Barriers and facilitators to antibiotic stewardship in Nigeria’s private healthcare sector: A qualitative interview study with national health and regulatory interest holders
Antimicrobial resistance (AMR) poses a growing global health concern, particularly in low- and middle-income countries (LMICs) such as Nigeria, where stewardship efforts have largely overlooked the private healthcare sector. Given that most Nigerians seek care from private providers, understanding the barriers and opportunities for implementing antibiotic stewardship programs in this setting is critical. We conducted a qualitative study consistin…
Health care (5 works) · Medicine (4 works) · Tuberculosis Research and Epidemiology (4 works) · Economic growth (3 works) · Nursing (3 works) · Antibiotic Use and Resistance (2 works) · Business (2 works) · Pandemic (2 works) · Political science (2 works) · Private sector (2 works)